These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21909807)

  • 1. [Serum-based biomarkers for psychiatric disorders].
    Bahn S; Schwarz E
    Nervenarzt; 2011 Nov; 82(11):1395-6, 1398, 1400 passim. PubMed ID: 21909807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges of introducing new biomarker products for neuropsychiatric disorders into the market.
    Bahn S; Noll R; Barnes A; Schwarz E; Guest PC
    Int Rev Neurobiol; 2011; 101():299-327. PubMed ID: 22050857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biomarker research in neuropsychiatry: challenges and potential].
    Gottschalk MG; Schwarz E; Bahn S
    Fortschr Neurol Psychiatr; 2013 May; 81(5):243-9. PubMed ID: 23695789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Proteomic Approaches to Accelerate Drug Development for Psychiatric Disorders.
    Rahmoune H; Martins-de-Souza D; Guest PC
    Adv Exp Med Biol; 2017; 974():69-84. PubMed ID: 28353225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the transdiagnostic nature of peripheral biomarkers in major psychiatric disorders: A systematic review.
    Pinto JV; Moulin TC; Amaral OB
    Neurosci Biobehav Rev; 2017 Dec; 83():97-108. PubMed ID: 28986182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The future of biomarkers in dementia diagnostics].
    Zimmermann R; Kornhuber J; Lewczuk P
    Nervenarzt; 2011 Nov; 82(11):1385-6, 1388, 1390, passim. PubMed ID: 21922304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of blood-based protein biomarker strategies in the study of psychiatric disorders.
    Chan MK; Gottschalk MG; Haenisch F; Tomasik J; Ruland T; Rahmoune H; Guest PC; Bahn S
    Prog Neurobiol; 2014 Nov; 122():45-72. PubMed ID: 25173695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic Approaches to Enable Point-of-Care Testing and Personalized Medicine for Psychiatric Disorders.
    Guest FL; Guest PC
    Adv Exp Med Biol; 2017; 974():363-370. PubMed ID: 28353256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future: biomarkers, biosensors, neuroinformatics, and e-neuropsychiatry.
    Lowe CR
    Int Rev Neurobiol; 2011; 101():375-400. PubMed ID: 22050860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies.
    Dean B
    Int J Neuropsychopharmacol; 2011 Aug; 14(7):997-1012. PubMed ID: 21156092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emergence of point-of-care blood-based biomarker testing for psychiatric disorders: enabling personalized medicine.
    Guest FL; Guest PC; Martins-de-Souza D
    Biomark Med; 2016; 10(4):431-43. PubMed ID: 26999493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Personalized psychiatry and psychotherapy. Realistic hope for the future or fiction?].
    Falkai P
    Nervenarzt; 2011 Nov; 82(11):1382, 1384. PubMed ID: 22038384
    [No Abstract]   [Full Text] [Related]  

  • 13. A Selected Reaction Monitoring Mass Spectrometry Protocol for Validation of Proteomic Biomarker Candidates in Studies of Psychiatric Disorders.
    Reis-de-Oliveira G; Garcia S; Guest PC; Cassoli JS; Martins-de-Souza D
    Adv Exp Med Biol; 2017; 974():213-218. PubMed ID: 28353238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood biomarker discovery in drug-free schizophrenia: the contributionof proteomics and multiplex immunoassays.
    Sabherwal S; English JA; Föcking M; Cagney G; Cotter DR
    Expert Rev Proteomics; 2016 Dec; 13(12):1141-1155. PubMed ID: 27771981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of Peripheral Blood Mononuclear Cells (PBMCs) as a Model for Proteomic Studies of Psychiatric Disorders.
    Rahmoune H; Guest PC
    Adv Exp Med Biol; 2017; 974():299-303. PubMed ID: 28353249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential biomarkers in psychiatry: focus on the cholesterol system.
    Woods AG; Sokolowska I; Taurines R; Gerlach M; Dudley E; Thome J; Darie CC
    J Cell Mol Med; 2012 Jun; 16(6):1184-95. PubMed ID: 22304330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
    Lee JW; Figeys D; Vasilescu J
    Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speculations on the Future of Psychiatric Diagnosis.
    Rush AJ; Ibrahim HM
    J Nerv Ment Dis; 2018 Jun; 206(6):481-487. PubMed ID: 29781887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Application of Multiplex Biomarker Techniques for Improved Stratification and Treatment of Schizophrenia Patients.
    Steiner J; Guest PC; Rahmoune H; Martins-de-Souza D
    Methods Mol Biol; 2017; 1546():19-35. PubMed ID: 27896755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood Sampling and Preparation Procedures for Proteomic Biomarker Studies of Psychiatric Disorders.
    Guest PC; Rahmoune H
    Adv Exp Med Biol; 2017; 974():141-147. PubMed ID: 28353230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.